Immunomedics, Inc.
(NASDAQ : IMMU)

( )
IMMU After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
-0.24%46.268.1%$690.49m
AMGNAmgen Inc.
-0.23%177.061.3%$495.97m
CELGCelgene Corporation
-0.72%90.871.3%$431.27m
GILDGilead Sciences, Inc.
-0.03%66.920.9%$401.89m
BIIBBiogen Inc.
-0.91%229.441.3%$372.09m
ILMNIllumina, Inc.
0.20%302.903.5%$354.87m
REGNRegeneron Pharmaceuticals, Inc.
0.35%299.422.6%$268.31m
ALXNAlexion Pharmaceuticals, Inc.
0.48%123.412.0%$197.95m
SRPTSarepta Therapeutics, Inc.
0.49%154.0014.7%$197.25m
VRTXVertex Pharmaceuticals Incorporated
0.56%177.141.9%$181.72m
AAgilent Technologies, Inc.
-0.52%69.591.6%$140.09m
EXASExact Sciences Corporation
1.21%116.3424.1%$137.96m
INCYIncyte Corporation
0.44%80.232.5%$110.35m
BLUEBluebird Bio, Inc.
4.33%139.4514.3%$97.87m
BMRNBioMarin Pharmaceutical Inc.
0.12%82.474.3%$84.42m

Company Profile

Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.